Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2025 No.06

Total 18 articles

Interpretation of guidance on CMC study and evaluation of antibody-drug conjugatesLI Qian, WU Yong-kai, WEI Wei, HE Wu

561-565

Research on the development trend of viral safety control technology and requirements for biotechnology products:taking ICH Q5A(R2)as an exampleSAI Wen-bo, YU Peng-li, WEI Wei

566-570

Common pharmaceutical issues and review considerations for biologics license applications of antibody productsZHAO Jing, WEI Wei, HE Wu

571-578

Avoid using beta-lactam antibiotics and relevant resistance genes in prokaryotic-expressed therapy recombinant protein productsKOU Ya-zhen, WEI Wei, CHENG Su-yuan

579-584

Review considerations for sequence variants of monoclonal antibody drugsWU Yong-kai, LI Qian, WEI Wei

585-589

Discussion of common communication problems and review considerations of therapeutic recombinant protein biologicsKAN Hong-jin, WEI Wei, CHENG Su-yuan

590-595

Considerations for quality study of recombinant protein-based radiopharmaceuticalsQIU Xiao, KOU Ya-zhen, WANG Xue, CHEN Hao, ZHANG Meng-meng, HE Wu

596-601

Case study on the application of validation technology in viral clearance process platformCHEN Hao, HE Wu

602-607

Research progress and CMC considerations on gene-editing medicinal productsLU Jia-qi, ZHOU Di, WEI Wei, HE Wu

608-613

Development concerns and validation of flow cytometry method in CMC research of cell therapy productsWANG Jing-yu, Wu Xue-ling, WEI Wei

614-618